Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistance
Eur Respir J
.
2017 Jun 1;49(6):1700223.
doi: 10.1183/13993003.00223-2017.
Print 2017 Jun.
Authors
Armand Van Deun
1
2
,
Chen-Yuan Chiang
3
4
5
Affiliations
1
International Union Against Tuberculosis and Lung Disease, Paris, France.
2
Mycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium.
3
International Union Against Tuberculosis and Lung Disease, Paris, France
[email protected]
.
4
Division of Pulmonary Medicine, Dept of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
5
Dept of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
PMID:
28572126
DOI:
10.1183/13993003.00223-2017
No abstract available
Publication types
Letter
Comment
MeSH terms
Antitubercular Agents
Fluoroquinolones*
Humans
Microbial Sensitivity Tests
Mycobacterium tuberculosis
Tuberculosis, Multidrug-Resistant*
Substances
Antitubercular Agents
Fluoroquinolones